## Biological background 
>Cardiovascular and metabolic diseases, collectively referred to as cardiometabolic diseases (CMDs), are associated with high morbidity and mortality as well as with considerable and increasing health-care costs1. The gut microbiome has emerged as a central factor affecting human health and disease2, 3, and CMDs are no exception.
*******************************************

## Data description
218 individuals with atherosclerotic cardiovascular disease (ACVD) VS 187 healthy controls
*******************************************

## Sample processing
Sample reads are processed using **mOTUs 2.0.0 on python 3.6.1** and scripts are showed
![flowchart](https://github.com/manli-zou/Atherosclerotic-cardiovascular-disease/blob/master/images/flowchart)
******************************************

## files for statistical analysis
### files information

./data-profiles/

taxonomy : asc-motu.csv
***********************************************

### References
1ï¼Œ*Jie Z, Xia H, Zhong S L, et al. The gut microbiome in atherosclerotic cardiovascular disease[J]. Nature communications, 2017, 8(1): 845.*


